Biotechnology corporation.
Medicare and Medicaid payment issues.
Medicare reimbursement for biosimilars.
Medicare reimbursement for novel therapies.
MACRA treatment of Part B drugs.
MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE
TODD STRATEGY GROUP
1201 New York Avenue, NW, 8th Floor, Washington, DC, 20005, US
DANIEL M TODD (Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid)
Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid